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OBJECTIVE: Ischemic preconditioning and some drugs can protect tissues from injury by preserving microcirculation.
This study evaluated vascular permeability in a hamster cheek pouch preparation using either short ischemic periods
or bradykinin as preconditioning stimuli followed by 30 min of ischemia/reperfusion.
METHOD: Sixty-six male hamsters were divided into 11 groups: five combinations of different ischemic frequencies
and durations (one, three or five shorts periods of ischemia, separated by one or five minutes) with 10 min intervals
between the ischemic periods, followed by 30 min ischemia/reperfusion; three or five 1 min ischemic periods with
10 min intervals between them followed by the topical application of histamine (2 mM); bradykinin (400 nM)
followed by 30 min of ischemia/reperfusion; and three control groups (30 min of ischemia/reperfusion or histamine
or bradykinin by themselves). Macromolecular permeability was assessed by injection of fluorescein-labeled dextran
(FITC-dextran, MW=150 kDa; 250 mg/Kg body weight), and the number of leaks/cm2 was counted using an
intravital microscope and fluorescent light in the cheek pouch.
RESULTS: Plasma leakage (number of leaks/cm2) was significantly reduced by preconditioning with three and five
1 min ischemic periods, one and three 5 min ischemic periods and by bradykinin. Histamine-induced macro-
molecular permeability was also reduced after three periods of 5 min of ischemia.
CONCLUSION: Short ischemic periods and bradykinin can function as preconditioning stimuli of the ischemia/
reperfusion response in the hamster cheek pouch microcirculation. Short ischemic periods also reduced histamine-
induced macromolecular permeability.
KEYWORDS: Ischemic Preconditioning; Bradykinin Preconditioning; Vascular Permeability; Microcirculation;
Hamster Cheek Pouch.
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INTRODUCTION
Mortality by cardiovascular disease is still an important
concernworldwide. According toWorld Health Organization
(WHO), in 2004, coronary heart disease was the second most
common cause of death in low- and middle-income countries
and the most common cause of death in high-income ones (1).
During an acute myocardial infarction, many attempts to
reestablish blood flow are performed by physicians to save as
many cardiomyocytes as possible before they are damaged by
ischemia. However, after blood flow normalization, reper-
fusion injury also restricts cell survival. Consequently,
larger myocardial infarct areas predict worse prognosis
due to the loss of contractile mass and inadequate ventricle
remodeling through hypertrophy, eventually causing heart
failure (2).
Preconditioning refers to a phenomenon wherein tissues
are rendered resistant to the deleterious effects of prolonged
ischemia and reperfusion by prior exposure to oxidants,
brief periods of vascular occlusion, endotoxin derivatives,
heat shock, a variety of pharmacological agents (chemical or
pharmacological preconditioning), or chronic ethanol con-
sumption (3). Of these perturbations, our best understand-
ing of the mechanisms involved in conferring protection is
related to ischemic preconditioning (IPC) (4).
Myocardial preconditioning has been developed to
minimize the effects of acute ischemia to the heart. In
1986, Murry et al. reported that four brief episodes of 5
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minutes of ischemia in the circumflex coronary in dogs
followed by 5 minutes of reperfusion reduced the infarct
size by 75% compared to controls (5). Since the publication
of that report, many studies have tried to explain the
mechanistic steps involved in the preconditioning process,
such as mitochondrial ATP-sensitive K+ channels, nitric
oxide, adenosine and bradykinin (BK) (6-8).
Several studies in the hamster cheek pouch (HCP) on
experimental perturbations with drugs and the subsequent
responses suggest that it could be a useful model for studies
of IPC and other types of preconditioning (9-12). In a study
of ischemia/reperfusion (I/R) in the HCP, a period of 30
minutes of ischemia resulted in a 30% reduction in plasma
leakage in response to a second ischemic period, although
the response to histamine appeared unchanged (12).
The main element affected by ischemia that determines
cell survival is the microcirculation, the smallest vessels of
the vascular system; the endothelium plays a key role in the
ischemic process. Endothelial barrier dysfunction is a well-
recognized response to ischemia, which involves inflamma-
tion (13). Many changes occur in the structure of the
endothelial monolayer; one example is the widening of
paracellular junctions caused by the dissociation of junc-
tional proteins or cytoskeletal contractions (14,15). Increased
microvascular permeability results in edema and organ
failure. The magnitude of albumin leakage from post-
ischemic venules during ischemia-reperfusion injury was
reportedly proportional to the number of adherent and
emigrated leucocytes (16). However, histamine, normally
associated with allergic reactions and increases in vascular
permeability through H2 action, has been shown to decrease
inflammation by reducing chemotactic responsiveness of
leukocytes (17,18). Adachi et al. demonstrated that diphen-
hydramine, a histamine H1 receptor antagonist, inhibits
histamine-N-methyltransferase, which is a histamine-inacti-
vating enzyme in the brain. Thus, brain histamine amelio-
rated reperfusion injury after cerebral ischemia in rats (19).
The combination of biogenic amines such as histamine,
bradykinin and ischemic preconditioning may minimize the
deleterious effects of ischemia-reperfusion injury on the
microcirculation.
The main objectives of this work were to test the use of
the hamster cheek pouch as a model of preconditioning
and the effects of different frequencies and durations of
brief ischemic preconditioning (IP) episodes followed by 30
minutes of total ischemia and reperfusion or histamine
compared to the topical application of bradykinin followed
by ischemia/reperfusion on microvascular permeability in
hamster cheek pouch preparations.
MATERIALS AND METHODS
This study was approved by the Ethical Committee of the
State University of Rio de Janeiro, RJ, Brazil (CEA/215/2007).
Sixty-six male Syrian golden hamsters (Mesocricetus auratus,
Botucatu, Sa˜o Paulo, SP, Brazil), weighing between 80 g to
100 g, were randomly divided into eleven experimental
groups: control (C) - 30 minutes of ischemia; 1ischem19 - 1
minute of ischemia (IP) followed by 20minutes of waiting time
and 30minutes of ischemia; 3ischem19 - three 1minute periods
of ischemia with 10-minute intervals between them (IP),
followed by 20 minutes of waiting time and 30 minutes of
ischemia; 5ischem19 - five 1 minute periods of ischemia with
10-minute intervals between them (IP), followed by 20minutes
of waiting time and 30 minutes of ischemia; 1ischem59 – 5
minutes of ischemia (IP) followed by 20 minutes of waiting
time and 30 minutes of ischemia; 3ischem59 - three 5- minute
periods of ischemia with 10-minute intervals between them
(IP), followed by 20 minutes of waiting time and 30 minutes of
ischemia; 3ischem19_Hista – three one minute periods of
ischemiawith 10-minute intervals between them (IP), followed
by 20 minutes of waiting time and the topical application of
histamine (2 mM); 3ischem59_Hista - three 5 minutes periods
of ischemia with 10-minute intervals between them (IP),
followed by 20minutes of waiting time and topical application
of histamine (2 mM); control_Hista - topical application of
histamine (2 mM); BK - preconditioning with bradykinin (BK)
was achieved by the topical application of 400 nM BK for 5
minutes, followed after 20 minutes by either 30 minutes of
ischemia or no treatment (control) (Figure 1).
Hamster cheek pouch preparation
The hamster cheek pouch was prepared according to
studies by Duling (1973) (20), Svensjo¨ et al. (1978) (21),
modified by Persson et al. (1985) (12) and by Bouskela and
Grampp (1992) (22) (Figure 2A and B). Anesthesia was
induced by an intraperitoneal injection of sodium pentobar-
bital (0.2 ml/100 g body weight, pentobarbital sodium,
Sanofi, Paris, France, 60 mg/ml). After cannulation of the
femoral vein, anesthesia was maintained with an injection of
alpha-chloralose (2.5 ml/kg body weight, Merck, Darmstadt,
Germany). Thirty minutes after the preparation was com-
pleted, fluorescein-labeled dextran (FITC-dextran, MW=
150 kDa; 250 mg/kg bodyweight) was injected intravenously
as a macromolecular tracer.
The cheek pouch (Figure 2B) was subjected to ischemic
periods of different durations with an inflatable cuff made
of thin latex tubing, mounted around the neck of the everted
pouch where it leaves the mouth of the hamster. The cuff
did not disturb the local blood flow, and an intracuff
pressure of 200–220 mmHg created by air compression with
a syringe resulted in complete arrest of the microvascular
blood flow within few seconds (12).
Increases in microvascular permeability for large mole-
cules (plasma leakage) was quantified by counting sites
with extravasation of fluorescent plasma (leaky sites = leaks)
at post-capillary venules at 2–5 min intervals after the onset
of reperfusion and/or topical application of bradykinin
(400 nM) or histamine (2 mM) for 5 minutes. The results are
reported as the number of leaks counted 10 minutes after
the onset of reperfusion.
Statistical Analysis
Results are reported as means¡standard deviations
unless otherwise noted. For statistical analyses, ANOVA
was used to compare groups to controls. p,0.05 was
considered to indicate a statistically significant difference.
RESULTS
Brief 1- to 5-minute periods of ischemia followed by
reperfusion caused no visible increases in the number of
leaks or plasma leakage. One period of 1 minute of ischemia
had influence (p.0.05) on the subsequent 30-minute period
of I/R on plasma leakage, but several brief ischemic periods
reduced the response to the 30-minute period of ischemia as
shown in Figure 3A. Three periods of 5 minutes of ischemia
produced a significant reduction of the response to the
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subsequent 30 minutes of I/R. When logarithmic values of
the maximal number of leaks induced by 30 minutes of
ischemia were plotted versus the total duration of ischemia
during IPC, a linear correlation could be observed
(Figure 3B).
Figure 4 shows two IPC groups with three one-minute
and three five-minute ischemia periods followed by the
topical application of histamine compared to control. Three
occlusions of five minutes produced the fewest leaks
compared to the control group. Bradykinin also contrib-
uted microcirculatory protection. Five-minute topical
applications of 400 nM bradykinin given 30 minutes prior
to I/R reduced the response to I/R-induced plasma
leakage from 125 to 40 leaks/cm2 (32% of the I/R con-
trol group) and reduced the bradykinin-induced plasma
leakage from 305 to 226 leaks/cm2 (74% of the control
group) (Figure 5).
Table 1 displays the results as means and standard devia-
tions of leaks in the 3ischem19, 3ischem19_Hista, 3ischem59,
and 3ischem59_Hista groups. Additionally, it is possible to
visualize the percentage of leaks from each group with the
associated control values. There was no statistical difference
Figure 1 - The experimental protocol of the present study. Groups with one, three, and five one-minute ischemic periods: 1ischem19,
3ischem19, and 5ischem19. Groups with one and three five-minute ischemic periods: 1ischem59 and 3ischem59. Groups with three one-
minute and three five-minute ischemic periods followed by histamine: 3ischem19-Hista and 5ischem19_Hista. All ischemic periods had
10-minute rest intervals between them. Bradykinin group (BK) and three control groups: ischemia/reperfusion, histamine, and
bradykinin (control, Control_Hista, Control_BK).
Figure 2 - A. Hamster cheek pouch (HCP) model. B. The inflatable cuff mounted around the neck of the prepared cheek pouch (HCP).
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between the 3ischem19 and 3ischem19_Hista groups concern-
ing the percentage of leaks. However, the decreases in the
percentage of leaks from the 3ischem59 and 3ischem59_Hista
groups compared to 3ischem19 and 3ischem19_Hista were
highly significant. Further, the decrease in the percentage of
leaks was much more evident in the 3ischem59 group than in
the 3ischem59_Hista group.
DISCUSSION
The hamster cheek pouch as prepared for intravital
microscopy has been used in several studies to elucidate
the mechanisms behind I/R-induced increases in plasma
leakage. A 30-minute period of ischemia was originally
selected because it resulted in statistically significant and
reproducible increases in plasma leakage during reperfu-
sion, whereas 5-minute ischemic periods produce no visible
changes in plasma leakage (12). However, the possible effect
of IPC on I/R-, histamine and bradykinin induced plasma
leakage has not been studied in the HCP.
This study confirmed that repeated minor episodes of
ischemia have a protective effect on the microcirculation.
This is a natural phenomenon where several primary
pathways converge to cardioprotective effect (24,25). Not
all of the mechanisms involved in this cardioprotection are
known, and our first question in this study was how long
the cheek pouch vessels should be occluded to decrease the
microvascular permeability during I/R. We found that a
one-minute ischemic period was not enough to reduce the
number of leaks during reperfusion. We tested three and
five one-minute ischemic periods with ten-minute reflow
periods, and the results revealed a decreasing number of
leaks. The greatest reduction in plasma leakage induced by
30 min I/R were observed with one and three five-minute
ischemic periods with the same reflow time. Murry et al.
used 15-minute occlusions to precondition myocardial
Figure 3 - Effect of brief periods of ischemia and reperfusion prior to a period of 30 minutes of ischemia. A. Plasma leakage (maximal
number of leaks¡SD) induced at reperfusion after 30 minutes of ischemia following brief periods of ischemia/reperfusion in six groups
of hamsters (each group, n= 6) prior to the final 30 minute-ischemic period. #=p, 0.05, *=p,0.01 as compared with I/R controls. B.
Log-linear relationship between the number of leaks and the total ischemic period prior to the final 30 min I/R.
Figure 4 - Effect of brief periods of I/R prior to histamine application. Plasma leakage (maximal number of leaks¡SD) induced by
histamine (2 mM). Three periods of 1 or 5 minutes of ischemia reduced the subsequent response to histamine. *=p,0.05, # p,0.01 as
compared with histamine controls (2 mM).
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tissue in dogs with high mortality (5). When they attempted
to use more occlusions with smaller durations, including
four five-minute occlusions with 5-minute reflow between
them, they observed protective effects on the myocardium.
At 10 minutes reflow period, the maximum number of leaks
occured and for that reason we have chosen this time to
report. We could also demonstrate that the log of IPC-
induced reduction was linearly correlated to the total
duration of ischemia for 15 minutes (Figure 3B) suggesting
that the preconditioning effect was related to the total time
of ischemic rather than the number of ischemic periods.
Preconditioning can protect the heart and other tissues
from a subsequent sustained period of ischemia. Early
preconditioning is independent of protein synthesis, and
the prolonged insult should be less than 2 hours (28). Our
model used 30 minutes of total ischemia. Prolonged ische-
mia will produce impaired endothelial-dependent vasodila-
tion, capillary plugging, increased adhered and transmi-
grated leukocytes and venous protein leakage (28). Ischemic
preconditioning protects endothelial cells and reverses mic-
rocirculatory injury caused by ischemia (3).
The effect of IPC (361 min) on histamine-induced plasma
leakage did not differ from that observed with I/R; the
respective effects were 79% and 78% of the non-IPC-control
group response. When the IPC-period was prolonged
(365 min), further 63% and 40% reductions were observed
in the histamine and I/R groups, respectively, compared to
the non-IPC-control group. A similar histamine-precondi-
tioning effect was observed by Erlansson et al. (1985), who
reported that in a series of four repeated histamine
challenges, the second, third, and fourth challenges produced
plasma leakages that were each 65% of the first challenge (12).
Taken together, these results may suggest that the precondi-
tioning effect is more related to the strength of the stimuli (the
duration of ischemic periods or the dose of histamine) on
endothelial cells, rather than the nature of preconditioning
(IPC or histamine). In this context, it is interesting to note that
in a study using HCP an antioxidant (flavonoid) reduced the
plasma leakage responses induced by histamine, bradykinin
and I/R to 26%, 32% and 31%, respectively, of the control
group without antioxidant pretreatment (23).
Delbin et al. have shown that histamine did not influence
pulmonary ischemia/reperfusion injury in sedentary or
preconditioned exercised rats (five days a week for eight
weeks) (29). However, increased nitric oxide (NO) release
after regular physical exercise is cardioprotective (30).
Perhaps ischemic preconditioning protection is different
from the protection developed from exercise training.
Indeed, IPC prevented the impairment of pulmonary
endothelium-dependent vasodilation partially due to nitric
oxide (NO) release in isolated rat lungs (31).
In this study we observed a significant preconditioning
effect of three one-minute and three five-minute ischemic
periods (Table 1) when tested with 30 min I/R and with
histamine (2mM). There was no difference in the precondi-
tioning effect with one-minute ischemic periods (78 % and
79% of control). However, the three five-minute ischemic
periods induced a greater preconditioning effect in the 30
min I/R group (39% of control) than in the histamine group
(63% of control) suggesting a difference in the mechanism
of plasma leakage induction due to ROS formation and the
direct receptor stimulation with histamine. Indeed during
ischemia in the HCP the presence of reactive oxygen species
have been observed (32), and with the addition of histamine,
calcium channels may exhibit more prominent action after
three five-minute ischemic periods. Some studies have
shown the contribution of histamine to ischemic precondi-
tioning and microcirculation. Kandilci et al. prevented the
decrease in pulmonary vasodilator response to histamine
and acetylcholine following two hours of hypothermic
ischemia in rats using two 5-minute cycles of ischemia
and reperfusion (33). Moreover, Wang et al. demonstrated
that mast cell granules are not affected by ischemic
preconditioning. The theory behind this finding was that
an initial brief ischemia would result in mast cell degranu-
lation without significant cardiovascular damage, but when
a prolonged ischemic episode would occur, no more
degranulation could be possible (34).
Figure 5 - Plasma leakage (maximal number of leaks¡SD) induced by ischemia/reperfusion (I/R) and 400 nM bradykinin (BK) without
(Triangles) or with (Diamonds) bradykinin prior to I/R. Bradykinin prior to I/R reduced the subsequent response to I/R (from 125 to 40
leaks - 32% of control) and to bradykinin (from 305 to 225.7 leaks - 74% of control), * p,0.05.
CLINICS 2012;67(8):923-929 Preconditioning and microcirculation
Conceic¸a˜o FG et al.
927
We have observed the preconditioning effect of bradykinin
on ischemia/reperfusion by reducing plasma leakage com-
pared to the control group. In clinical practice, exogenous
administration of bradykinin prior to cardiopulmonary
bypass in coronary artery bypass grafting reducesmyocardial
injury (35). Bradykinin can also be considered an endothe-
lium protector. Indeed, in vitro experiments with pig cerebral
endothelial cells exposed to necrotic and apoptotic cell
inducers (H2O2) demonstrated enhanced expression of the
cytoprotective proteins COX-2 and (Cu/Zn) SOD when the
cells were pretreated with bradykinin (36). Nevertheless,
nitrite production in response to bradykinin was enhanced
in microvessels during second window protection (SWOP)
in dogs subjected to myocardial preconditioning with 10
minutes of coronary artery occlusion (37). Further, endothe-
lial nitric oxide synthase (eNOS) protein in the SWOP
myocardium was twofold higher than in control groups.
Our study has demonstrated a preconditioning effect of
short periods of ischemia and reperfusion when measured
as plasma leakage induced by a 30 min I/R-period. This
preconditioning effect (reduction in the response to 30 min
I/R-induced plasma leakage) that was log-linear related to
the total time of brief ischemic periods. When the same
preconditioning protocol was applied before histamine
application a similar but smaller reduction in the plasma
leakage was observed. A preconditioning effect was also
observed after topical application of bradykinin 30 minutes
prior to I/R-induced plasma leakage that was of the same
magnitude as that induced by brief ischemic periods.
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